1. Swerdlow, SH, Campo, E, Pileri, SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016; 127(20): 2375–2390.
Google Scholar | Crossref | Medline | ISI2. Quesada, AE, Medeiros, LJ, Clemens, MW, et al. Breast implant-associated anaplastic large cell lymphoma: a review. Mod Pathol 2019; 32(2): 166–188.
Google Scholar | Crossref | Medline3. Ferrufino-Schmidt, MC, Medeiros, LJ, Liu, H, et al. Clinicopathologic features and prognostic impact of lymph node involvement in patients with breast implant-associated anaplastic large cell lymphoma. Am J Surg Pathol 2018; 42(3): 293–305.
Google Scholar | Crossref | Medline4. Bizjak, M, Selmi, C, Praprotnik, S, et al. Silicone implants and lymphoma: the role of inflammation. J Autoimmun 2015; 65: 64–73.
Google Scholar | Crossref | Medline | ISI5. Kim, B, Roth, C, Chung, KC, et al.Anaplastic large cell lymphoma and breast implants: a systematic review. Plast Reconstr Surg 2011; 127(6): 2141–2150.
Google Scholar | Crossref | Medline6. Shahriari, N, Ferenczi, K, Heald, PW. Breast implant-associated anaplastic large cell lymphoma: A review and assessment of cutaneous manifestations. Int J Womens Dermatol 2017; 3(3): 140–144.
Google Scholar | Crossref | Medline7. Duvic, M, Moore, D, Menter, A, et al. Cutaneous T-cell lymphoma in association with silicone breast implants. J Am Acad Dermatol 1995; 32(6): 939–942.
Google Scholar | Crossref | Medline8. Xu, J, Wei, S. Breast implant-associated anaplastic large cell lymphoma: review of a distinct clinicopathologic entity. Arch Pathol Lab Med 2014; 138(6): 842–846.
Google Scholar | Crossref | Medline9. Clemens, MW, Jacobsen, ED, Horwitz, SM. 2019 NCCN consensus guidelines on the diagnosis and management of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Aesthet Surg J 2019; 39: S3–S13.
Google Scholar | Crossref | Medline